Michael A. Brehm, PhD
Associate Professor of Molecular Medicine and Co-Director of the Humanized Mouse Core Facility at UMass Medical School, Investigator at the JDRF Center of Excellence in New England
Dr. Brehm works with these unique animal models of human immune responses to investigate approaches to downregulate as well as activate the human immune system for treatments of type 1 diabetes (T1D) and cancer. Dr. Brehm's laboratory studies human beta cells from individuals with type 1 diabetes in a real-life setting as they interact with intact T1D immune systems. The ultimate objective is to understand the etiology and pathogenesis of autoimmune T1D, in order to develop new therapies and drugs for personalized medicine.
Researcher Spotlight: Sushobhana Bandyopadhyay, PhD
In this video Dr. Bandyopadhyay explains how the Brehm Lab is studying human cells to better understand the autoimmune attack that occurs in people with Type 1 diabetes
Meet Dr. Michael Brehm
Researcher Spotlight: Pamela St. Louis
Pam is a Senior Scientist in the Brehm Lab. She combines her loves for animals and science with our pre-clinical model, investigating potential treatments for human trials.